WO2024167084A1 - Emulsion using rhodococcus koreensis strain and composition for improving skin condition comprising fermented product thereof - Google Patents
Emulsion using rhodococcus koreensis strain and composition for improving skin condition comprising fermented product thereof Download PDFInfo
- Publication number
- WO2024167084A1 WO2024167084A1 PCT/KR2023/014289 KR2023014289W WO2024167084A1 WO 2024167084 A1 WO2024167084 A1 WO 2024167084A1 KR 2023014289 W KR2023014289 W KR 2023014289W WO 2024167084 A1 WO2024167084 A1 WO 2024167084A1
- Authority
- WO
- WIPO (PCT)
- Prior art keywords
- culture
- composition
- rhodococcus
- strain
- manufacturing
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Ceased
Links
Images
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K8/00—Cosmetics or similar toiletry preparations
- A61K8/02—Cosmetics or similar toiletry preparations characterised by special physical form
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K8/00—Cosmetics or similar toiletry preparations
- A61K8/02—Cosmetics or similar toiletry preparations characterised by special physical form
- A61K8/04—Dispersions; Emulsions
- A61K8/06—Emulsions
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K8/00—Cosmetics or similar toiletry preparations
- A61K8/18—Cosmetics or similar toiletry preparations characterised by the composition
- A61K8/96—Cosmetics or similar toiletry preparations characterised by the composition containing materials, or derivatives thereof of undetermined constitution
- A61K8/99—Cosmetics or similar toiletry preparations characterised by the composition containing materials, or derivatives thereof of undetermined constitution from microorganisms other than algae or fungi, e.g. protozoa or bacteria
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61Q—SPECIFIC USE OF COSMETICS OR SIMILAR TOILETRY PREPARATIONS
- A61Q19/00—Preparations for care of the skin
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N1/00—Microorganisms, e.g. protozoa; Compositions thereof; Processes of propagating, maintaining or preserving microorganisms or compositions thereof; Processes of preparing or isolating a composition containing a microorganism; Culture media therefor
- C12N1/20—Bacteria; Culture media therefor
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12R—INDEXING SCHEME ASSOCIATED WITH SUBCLASSES C12C - C12Q, RELATING TO MICROORGANISMS
- C12R2001/00—Microorganisms ; Processes using microorganisms
- C12R2001/01—Bacteria or Actinomycetales ; using bacteria or Actinomycetales
Definitions
- the present invention relates to a cosmetic composition for improving skin condition.
- a multiple emulsion is a system composed of smaller, different-phase emulsions within an emulsion. It refers to a multi-phase emulsion created when the emulsion is added to another continuous phase and stirred, and is mainly used in fields such as cosmetics, drug delivery, and food. Multiple emulsions can be largely divided into W/O/W (water in oil in water) emulsions and O/W/O (oil in water in oil) emulsions.
- a W/O/W multiple emulsion is a form in which a W/O emulsion of the inner phase is redispersed in an outer aqueous phase, and the dispersed phase itself has a unique overlapping structure that contains different small dispersed particles to become a continuous phase.
- W/O/W multiple emulsions can secure the moisturizing effect, which is the advantage of W/O emulsions, and the refreshing feeling, which is the advantage of O/W emulsions, at the same time, and can be used by adding active substances that react with each other to the inner and outer phases, respectively.
- W/O/W multiple emulsions have larger droplets and are not uniform in size compared to simple emulsions, which makes it easy for droplets to coalesce or separate into phases, and when the energy balance and osmotic pressure between the inner and outer phases are not balanced, the innermost phase and the outermost phase may coalesce and eventually turn into an O/W emulsion, etc., have problems.
- the inventors of the present invention sought to develop a composition that has the advantages of a W/O/W multiple emulsion, while simplifying the process and improving stability by utilizing the emulsification phenomenon using microorganisms rather than the complicated manufacturing process of the existing W/O/W multiple emulsion, and developed a multiple emulsion composition with excellent skin usability and skin improvement effect from a fermented product of microorganisms using non-animal raw materials.
- One aspect provides a method for producing an emulsion composition, comprising the steps of: producing a seed culture by culturing a Rhodococcus koreensis strain; producing a pre-culture by pre-cultivating the seed culture; and inoculating the pre-culture into a culture medium containing oil and performing fermentation.
- Another aspect provides a cosmetic composition for improving skin, comprising a culture or fermented product of Rhodococcus koreensis.
- Another aspect provides a medium composition for culturing a Rhodococcus koreensis strain.
- Rhodococcus koreensis strain BT1 deposited under the accession number KCCM12825P, comprising 16S rRNA of sequence number 1, and a culture medium thereof.
- One aspect is to provide a method for producing an emulsion composition, comprising the steps of: producing a seed culture by culturing a Rhodococcus koreensis strain; producing a pre-culture by pre-cultivating the seed culture; and inoculating the pre-culture into a culture medium containing oil and fermenting it.
- the emulsion composition may be characterized in that it is a multiple emulsion composition.
- multiple emulsion in this specification refers to a system in which smaller emulsions of different phases are composed within an emulsion, and may mean a multi-phase emulsion generated when the emulsion is stirred while being added to another continuous phase.
- Multiple emulsions can be largely divided into W/O/W (water in oil in water) emulsions and O/W/O (oil in water in oil) emulsions.
- W/O/W multiple emulsion is a form in which a W/O emulsion of an inner phase is redispersed in an outer water phase, and may have an overlapping structure in which the dispersed phase itself contains different small dispersed particles to become a continuous phase.
- the above multiple emulsion composition may be a W/O/W multiple emulsion composition.
- the aqueous phase of an emulsion containing a Rhodococcus koreensis BT1 (KCCM 13266P) culture was stained with 5-carboxyfluorescein and observed under a fluorescence microscope, and it was confirmed that the multiphase structure had small emulsions in the aqueous phase within a relatively large emulsion (Fig. 5).
- the multi-emulsion composition may be characterized by having a form of a bio-liquid crystal.
- liquid crystal refers to a system that is created when organic molecules having hydrophilicity and lipophilicity as an intermediate phase between a solid and a liquid are arranged in a lamellar structure in which the hydrophilic parts are arranged hydrophilically and the hydrophobic parts are arranged hydrophobically to form multiple layers.
- bio-liquid crystal as used herein may refer to a liquid crystal manufactured using a fermentation process of a microorganism, and may include a culture solution or fermented product of the Rhodococcus coriensis strain.
- the above liquid crystal has a structure similar to the intercellular lipid of the stratum corneum of the skin, so it has excellent affinity with skin lipids and can form a skin protective film, so it can be used in cosmetic compositions, etc.
- the bio-liquid crystal is characterized by being a lamellar-type spherical multiple liquid crystal having a hexagonal (Maltese cross) multi-layer particle shape, and the bio-liquid crystal particle may have a particle size of 10 to 50 ⁇ m.
- Example 1 and Comparative Example 1 as a result of microscopically photographing multiple emulsions (Example 1 and Comparative Example 1) before and after fermentation, it was confirmed that in the case of Example 1, an emulsion with a uniform particle size was formed after fermentation compared to before fermentation in Comparative Example 1 (FIGS. 1 and 2).
- the microorganism that produces a multiple emulsion capable of taking on a bio-liquid crystal form through a fermentation process may be " Rhodococcus koreensis", and more specifically, may be the Rhodococcus koreensis BT1 strain deposited under the deposit number KCCM 13266P.
- the Rhodococcus koreensis BT1 strain may include 16s rRNA of sequence number 1.
- shaking culture may be performed using an LB medium, but there is no particular limitation to this as long as it is a medium or culture method that contains components necessary to activate the above strain.
- the step of preparing the seed culture or pre-culture may be performed under conditions of 10 to 30° C. and 100 to 300 rpm for 24 to 72 hours.
- the step of preparing a fermented product by inoculating the pre-culture into a culture medium containing oil may be performed under aerobic conditions of 10 to 30° C., 100 to 300 rpm, 0.5 to 2.0 vvm, and pH 5.5 to 6.5 for 24 to 120 hours.
- the above culture medium is for performing the main culture of the activated preculture, and may contain at least one selected from the group consisting of KH2PO4 , K2HPO4 , ( NH4 ) 2SO4 , MgSO4 ⁇ 7H2O , H3BO4 , CaCl2 , NaMoO4 ⁇ 2H2O , FeNaEDTA , FeSO4 ⁇ 7H2O , ZnSO4 ⁇ H2O , MnSO4 ⁇ H2O , NiCl2 ⁇ H2O , CuSO4 ⁇ 5H2O , MnCl2 , and CoCl2 ⁇ 6H2O , but is not particularly limited thereto.
- the culture medium contains KH2PO4 , 0.5 to 10 g/L, K2HPO4 , 5 to 20 g/L, ( NH4 ) 2SO4 , 10 to 30 g/L, MgSO4 ⁇ 7H2O , 0.001 to 2 g/L, H3BO4 , 1 to 10 mg/L, CaCl2, 1 to 50 mg/L, NaMoO4 ⁇ 2H2O , 1 to 10 mg/L, FeNaEDTA, 0.1 to 1 mg/L, ZnSO4 ⁇ H2O , 0.1 to 1 mg/L, MnSO4 ⁇ H2O , 0.01 to 0.1 mg/L, NiCl2 ⁇ H2O , 0.01 to 0.1 mg/L, CuSO4 ⁇ 5H2O , 0.01 to 0.1 mg/L, MnCl 2 0.01 to 0.1 mg/L, CoCl 2 ⁇ 6H 2 O 0.01 to 0.1 mg/L, and vegetable oil 1 to 100
- the above oil is for supplying a carbon source to the above microorganism or strain and may be a vegetable oil.
- the vegetable oil may be extracted from at least one selected from the group consisting of, for example, canola, grape seed, sunflower seed, olive, soybean, argan, rice bran, perilla seed, sesame seed, almond, macadamia, rosehip, coconut, peanut, corn, tiger nut, shea fruit, oil palm, bergamot fruit, vitamin tree seed, camellia seed, safflower seed, apricot seed, poppy seed, evening primrose seed, castor seed, green tea seed, meadowfoam seed, flax seed, hemp seed and rapeseed, and may be specifically, rapeseed oil, but is not particularly limited thereto.
- the method for producing the multi-emulsion composition may further include a step of heat treating at 10 to 100° C. for 5 to 200 minutes after the step of producing the fermented product.
- a step of removing remaining microbial fragments using a centrifuge may be further included after the step of heat treating.
- the above culture solution or fermented product may be produced through a step of producing a culture by culturing a Rhodococcus coriensis strain as a culture medium; a step of producing a pre-culture by pre-cultivating the culture medium; and a step of producing a fermented product by inoculating the pre-culture into a culture medium containing oil.
- the above skin improvement may be, but is not particularly limited to, skin barrier strengthening or skin moisturizing.
- skin barrier strengthening may mean any action that enhances the function of the skin barrier, which is located at the outermost part of the skin and prevents moisture loss
- skin moisturizing may mean any action that maintains moisture in the skin or prevents moisture loss.
- the cosmetic composition may be characterized as being a W/O/W multiple emulsion composition, and the multiple emulsion composition may be characterized as having a form of bio-liquid crystal.
- the medium composition may include at least one selected from the group consisting of oil; and KH 2 PO 4 , K 2 HPO 4 , (NH 4 ) 2 SO 4 , MgSO 4 ⁇ 7H 2 O, H 3 BO 4 , CaCl 2 , NaMoO 4 ⁇ 2H 2 O, FeNaEDTA, FeSO 4 ⁇ 7H 2 O, ZnSO 4 ⁇ H 2 O, MnSO 4 ⁇ H 2 O, NiCl 2 ⁇ H 2 O, CuSO 4 ⁇ 5H 2 O, MnCl 2 and CoCl 2 ⁇ 6H 2 O, but is not particularly limited thereto.
- Rhodococcus koreensis BT1 strain deposited under the accession number KCCM12825P, comprising 16S rRNA of sequence number 1, and a culture medium thereof.
- the present invention relates to a method for producing a multiple emulsion composition during fermentation of microorganisms, which has excellent usability without the complicated process of existing multiple emulsions, and a multiple emulsion cosmetic composition produced by this method can take the form of a bio-liquid crystal, and has excellent effects of strengthening the skin barrier and moisturizing without irritating the skin, so that it can be used for skin improvement purposes.
- Figure 1 shows microscopic photographs of the multiple emulsions of the present invention (Example 1 and Comparative Example 1) before and after fermentation.
- Figure 2 shows the particle size distribution of multiple emulsions (Example 1 and Comparative Example 1) before and after fermentation.
- Figure 3 shows photographs comparing the degree of emulsification by strain in Example 1, Comparative Example 1, and Comparative Examples 3 to 6.
- Figure 6 shows a photograph confirming the formation of bio-liquid crystals in each multiple emulsion.
- Figure 7 shows the results of comparing the thermal stability of a multiple emulsion (Example 1) having a bio-liquid crystal form (micrographs taken before and after heat treatment).
- Figure 8 shows the results of comparing the effects of the multiple emulsions of the present invention (Example 1, Comparative Example 1, and Comparative Examples 3 to 6) on the expression of the skin barrier factor filaggrin (FLG).
- Figure 9 shows the results of comparing the effects of the multiple emulsions of the present invention (Example 1, Comparative Example 1) on the expression of the skin barrier factor caspase-14 (CASP-14).
- Figure 10 shows the results of comparing the effects of the multiple emulsions of the present invention (Example 1, Comparative Example 1) on the expression of the moisture-retaining factor hyaluronan synthase-2 (Hyaluronic acid synthase-2; HAS-2).
- Example 1 Preparation of an emulsion containing a culture of Rhodococcus coriensis strain
- Rhodococcus koreensis BT1 (KCCM 13266P, 2022.11.11) was inoculated into LB medium and shaken at 30°C and 200 rpm for 48 hours to culture the spawn. Preculture was performed by inoculating 1% of the spawn culture into sterilized LB medium and shaking at 30°C and 200 rpm for 24 hours to culture the spawn. The goal was to induce maximum bacterial activation up to preculture to induce multiple emulsion formation in the main culture.
- the medium was composed of KH2PO4 5 g/L, K2HPO4 10 g/L, ( NH4 ) 2SO4 20 g/L, MgSO4 ⁇ 7H2O 0.2 g/L, H3BO4 5 mg/L, CaCl2 20 mg/L, NaMoO4 ⁇ 2H2O 5 mg/L, FeNaEDTA 0.5 mg/L, ZnSO4 ⁇ H2O 0.5 mg/L, MnSO4 ⁇ H2O 0.04 mg/L, NiCl2 ⁇ H2O 0.02 mg/L, CuSO4 ⁇ 5H2O 0.04 mg/L, MnCl2 0.02 mg/L, CoCl2 ⁇ 6H2O 0.04 mg/L, and rapeseed oil 25 g/ L . 3.5 L was prepared in a 5 L fermenter. The medium was inoculated with 1% of the pre-culture fermentation product and cultured for 96 hours under the conditions of 30°C, 100
- Table 1 below shows representative composition ratios for making a liquid crystal emulsion.
- the water phase was accurately weighed so that the total amount was 100 g, heated to 75 to 80°C to completely dissolve, and stored separately.
- the oil phase was accurately weighed, heated to 75 to 80°C to completely dissolve, and stored separately. Afterwards, the oil phase was slowly added to the water phase using a homomixer to sufficiently disperse it, and an emulsification reaction was performed at about 3,000 rpm for 5 minutes. Afterwards, it was cooled to room temperature to complete the defoaming process.
- Rhodococcus erythropolis KCCM40161 Comparative Example 3
- Rhodococcus ruber KCCM41053 Comparative Example 4
- Rhodococcus opacus KCCM41722 Comparative Example 5
- Candia bombiocola KCCM11858 Comparative Example 6
- Rhodococcus erythropolis KCCM40161 was inoculated into LB medium and cultured with shaking at 26°C and 200 rpm for 24 hours to culture the spawn.
- Preculture was performed by inoculating 1% of the above spawn culture into sterilized LB medium and cultured with shaking at 26°C and 200 rpm for 24 hours to culture the spawn. The aim was to induce the emulsification phenomenon in the main culture by maximally inducing the activation of the bacteria up to the preculture.
- the medium was composed of KH2PO4 5 g/L, K2HPO4 10 g/L, ( NH4 ) 2SO4 20 g/L, MgSO4 ⁇ 7H2O 0.2 g/L, H3BO4 5 mg/L, CaCl2 20 mg/L, NaMoO4 ⁇ 2H2O 5 mg/L, FeNaEDTA 0.5 mg/L, ZnSO4 ⁇ H2O 0.5 mg/L, MnSO4 ⁇ H2O 0.04 mg/L, NiCl2 ⁇ H2O 0.02 mg/L, CuSO4 ⁇ 5H2O 0.04 mg/L, MnCl2 0.02 mg/L, CoCl2 ⁇ 6H2O 0.04 mg/L, and rapeseed oil 25 g/ L . 3.5 L was prepared in a 5 L fermenter. The medium was inoculated with 1% of the pre-culture fermentation product and cultured for 96 hours under the conditions of 26°C, 100
- Rhodococcus ruber KCCM41053 was inoculated into LB medium and cultured with shaking at 28°C and 200 rpm for 48 hours to culture the spawn.
- Preculture was performed by inoculating 1% of the above spawn culture into sterilized LB medium and cultured with shaking at 28°C and 250 rpm for 24 hours to culture the spawn.
- the aim was to induce maximum activation of the bacteria up to the preculture to induce the emulsification phenomenon in the main culture, and the conditions for the main culture were the same as those of Example 1.
- Rhodococcus opacus KCCM41722 was inoculated into LB medium and cultured with shaking at 30°C and 200 rpm for 48 hours to culture the spawn.
- Preculture was performed by inoculating 1% of the above spawn culture into sterilized LB medium and cultured with shaking at 30°C and 200 rpm for 24 hours to culture the spawn.
- the preculture was performed to induce the emulsification phenomenon in the main culture by inducing the maximum activation of the bacteria up to the preculture, and the main culture conditions were the same as those of Example 1.
- Candia bombiocola KCCM11858 was inoculated into YM medium and cultured with shaking at 30°C and 200 rpm for 48 hours to culture the spawn.
- Preculture was performed by inoculating 1% of the above spawn culture into sterilized YM medium and cultured with shaking at 30°C and 200 rpm for 24 hours to culture the spawn.
- the preculture was performed to induce the emulsification phenomenon in the main culture by inducing the maximum activation of the fungus up to the preculture, and the main culture conditions were the same as those of Example 1.
- Example 1 As a result of taking microscopic photographs of multiple emulsions (Example 1 and Comparative Example 1) before and after fermentation, it was confirmed that in the case of Example 1, an emulsion with uniform particle size was formed after fermentation compared to before fermentation in Comparative Example 1 (Figs. 1 and 2).
- Example 1 the aqueous phase was stained with 5-carboxyfluorescein and observed under a fluorescence microscope, and it was confirmed that small emulsions in the aqueous phase existed inside a relatively large emulsion (Fig. 5), and from this, it was confirmed that the structure of the emulsion including the culture of Example 1 was a multiple emulsion of W/O/W.
- Example 1 using the strain of Rhodococcus koreensis BT1 of the present invention showed the highest emulsifying power. It was confirmed that Comparative Examples 3 and 6 were not emulsified, and Comparative Examples 4 and 5 showed an emulsifying appearance compared to Comparative Examples 3 and 6, but showed a large difference in the degree of emulsification and stability compared to Example 1 (Fig. 3).
- Example 1 formed a multiple emulsion by observing small emulsions inside a large emulsion, but it was confirmed that such a multiple emulsion structure was not observed for Comparative Examples 4 and 5 (Fig. 4).
- Example 1 As a result, in the case of Example 1, it was confirmed that a Maltese cross shape was observed similarly to Comparative Example 2, which is known to form a liquid crystal. On the other hand, in the case of Comparative Example 1, which was composed of materials unrelated to liquid crystal formation and did not use a surfactant, the Maltese cross shape was not observed at all (Fig. 6).
- Example 1 the stability of the multiple emulsion according to the heat treatment was evaluated. Specifically, the emulsion of Example 1 was heat treated at 70°C for 30 minutes and then the state was observed using a polarizing microscope. The particle size analysis was performed using SLS (LA-960, Horiba, Japan). As a result, in the case of Example 1, it was confirmed that the emulsion state and particle size exhibited thermal stability by comparing before and after the heat treatment (Fig. 7).
- Example 1 which is a multiple emulsion according to the present invention, has excellent spreadability compared to Comparative Examples 3 to 5, and also does not significantly generate the unique fermentation odor generated during fermentation.
- Example 1 had less stickiness and the highest moisturizing power compared to Comparative Examples 2 to 5.
- the multi-emulsion composition of the present invention has almost no fermentation odor characteristic of fermented compositions, is environmentally friendly, and has excellent usability.
- Example 1 The effects of the multiple emulsion of Example 1 on the skin barrier and moisturizing-related factors were analyzed. Specifically, human epidermal cells (HaCaT) and human dermal fibroblasts were cultured using DMEM (Dulbecco's Modified Eagle's Medium) medium containing 10% fetal bovine serum (FBS) and 1% penicillin, respectively, at 37°C in a 5% CO2 incubator. 3.0 x 10 4 cells were dispensed into a 96-well plate and cultured in an incubator for 24 hours. After 24 hours, the medium was replaced with new one, and the multiple emulsion sample of Example 1 was treated at the desired concentration and cultured for 24 hours.
- DMEM Dynamic Eagle's Medium
- FBS fetal bovine serum
- RT-qPCR Real-time Quantitative Polymerase Chain Reaction
- Example 1 and Comparative Example 1 and Comparative Examples 3 to 6 on the expression of FLG, a skin barrier factor, are shown in Fig. 8, the effects on CASP-14 expression are shown in Fig. 9, and the effects on HAS-2 expression are shown in Fig. 10.
- Example 1 As a result, the expression of Filaggrin, a skin barrier factor, was most significantly increased by Example 1, and it was confirmed that the skin barrier effect was the highest. In other comparative examples, no significant increase in FLG expression was observed compared to the untreated group (Control) (Fig. 8). In addition, it was confirmed that Example 1 increased the expression of CASP-14, another skin barrier factor, and HAS-2, a moisture retention factor, compared to the untreated group and Comparative Example 1 (Figs. 9 and 10).
Landscapes
- Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- General Health & Medical Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Engineering & Computer Science (AREA)
- Veterinary Medicine (AREA)
- Public Health (AREA)
- Animal Behavior & Ethology (AREA)
- Biotechnology (AREA)
- Epidemiology (AREA)
- Birds (AREA)
- Wood Science & Technology (AREA)
- Organic Chemistry (AREA)
- Zoology (AREA)
- Tropical Medicine & Parasitology (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Genetics & Genomics (AREA)
- Dermatology (AREA)
- Microbiology (AREA)
- Biomedical Technology (AREA)
- General Engineering & Computer Science (AREA)
- Virology (AREA)
- Biochemistry (AREA)
- Medicinal Chemistry (AREA)
- Dispersion Chemistry (AREA)
- Micro-Organisms Or Cultivation Processes Thereof (AREA)
Abstract
Description
본 발명은 피부 상태 개선용 화장료 조성물 등에 관한 것이다.The present invention relates to a cosmetic composition for improving skin condition.
일반적으로 다중 에멀젼(multiple emulsion)은 에멀젼 내에 더 작고 상이 다른 에멀젼으로 구성되어 있는 시스템으로, 에멀젼을 다른 연속상에 첨가하면서 교반할 때 생성되는 다상의 에멀젼을 의미하며 이는 화장품, 약물전달 또는 식품 등 분야에서 주로 활용되고 있다. 다중 에멀젼은 크게 W/O/W (water in oil in water) 에멀젼과 O/W/O (oil in water in oil) 에멀젼으로 나뉠 수 있는데, W/O/W 다중 에멀젼은 내상의 W/O 에멀젼이 외부수상에 재분산된 형태로, 분산상 자체가 다른 작은 분산 입자를 포함하고 있어 연속상이 되는 독특한 중복 구조를 갖는다. In general, a multiple emulsion is a system composed of smaller, different-phase emulsions within an emulsion. It refers to a multi-phase emulsion created when the emulsion is added to another continuous phase and stirred, and is mainly used in fields such as cosmetics, drug delivery, and food. Multiple emulsions can be largely divided into W/O/W (water in oil in water) emulsions and O/W/O (oil in water in oil) emulsions. A W/O/W multiple emulsion is a form in which a W/O emulsion of the inner phase is redispersed in an outer aqueous phase, and the dispersed phase itself has a unique overlapping structure that contains different small dispersed particles to become a continuous phase.
W/O/W 다중 에멀젼은 W/O 에멀젼의 장점인 보습력 강화 및 O/W 에멀젼의 장점인 산뜻한 사용감을 동시에 확보할 수 있고, 서로 반응하는 활성물질을 각각 내부 수상과 외부 수상에 각각 첨가하여 사용할 수 있다. 다만, W/O/W 다중 에멀젼은 단순 유화 에멀젼에 비해 액적이 크고 크기가 균일하지 않아 액적 간 합일이나 상이 분리되기가 쉽고, 내부와 외부 수상 간 에너지 밸런스 및 삼투압이 균형을 이루지 않을 경우 최내상과 최외상이 합일되어 결국 O/W 에멀젼으로 전상될 수 있는 등의 문제점이 있다. W/O/W multiple emulsions can secure the moisturizing effect, which is the advantage of W/O emulsions, and the refreshing feeling, which is the advantage of O/W emulsions, at the same time, and can be used by adding active substances that react with each other to the inner and outer phases, respectively. However, W/O/W multiple emulsions have larger droplets and are not uniform in size compared to simple emulsions, which makes it easy for droplets to coalesce or separate into phases, and when the energy balance and osmotic pressure between the inner and outer phases are not balanced, the innermost phase and the outermost phase may coalesce and eventually turn into an O/W emulsion, etc., have problems.
한편, 다중 에멀젼의 이러한 안정성 문제를 해결하기 위해 고급 알코올 및 글루코사이드 계열의 계면활성제를 사용하여 에멀젼의 점도를 증가시킬 경우 고급 알코올 기반 액정 에멀젼 특유의 뻑뻑한 사용감을 초래할 수 있고, 폴리에틸렌글리콜-다이아크릴레이트와 같은 고분자를 최내상에 도입할 경우 단단한 코어쉘 구조를 가진 W/O/W 다중 에멀젼을 제조할 수 있으나 부정적인 사용감을 초래하고 피부자극을 일으킬 수 있다. Meanwhile, in order to solve these stability problems of multiple emulsions, if high-grade alcohol and glucoside series surfactants are used to increase the viscosity of the emulsion, it may result in a sticky feeling characteristic of high-grade alcohol-based liquid crystal emulsions, and if a polymer such as polyethylene glycol-diacrylate is introduced into the innermost phase, a W/O/W multiple emulsion with a solid core-shell structure can be produced, but it may result in a negative feeling and cause skin irritation.
이러한 배경 하에 본 발명자들은 W/O/W 다중 에멀젼의 장점을 가지면서도 기존의 W/O/W 다중 에멀젼의 복잡한 제조공정이 아닌 미생물을 이용한 유화 현상을 활용하여 공정을 단순화하고 안정도를 향상시킨 조성물을 개발하고자 하였고, 비동물성 원료를 활용한 미생물의 발효물로부터 피부 사용성 및 피부 개선 효과가 우수한 다중 에멀젼 조성물을 개발하였다.Against this backdrop, the inventors of the present invention sought to develop a composition that has the advantages of a W/O/W multiple emulsion, while simplifying the process and improving stability by utilizing the emulsification phenomenon using microorganisms rather than the complicated manufacturing process of the existing W/O/W multiple emulsion, and developed a multiple emulsion composition with excellent skin usability and skin improvement effect from a fermented product of microorganisms using non-animal raw materials.
일 양상은 로도코커스 코리엔시스(Rhodococcus koreensis) 균주를 종균배양하여 종균배양물을 제조하는 단계; 상기 종균배양물을 전배양하여 전배양물을 제조하는 단계; 및 오일을 포함하는 배양 배지에 상기 전배양물을 접종하여 발효시키는 단계를 포함하는, 에멀젼 조성물의 제조방법을 제공한다.One aspect provides a method for producing an emulsion composition, comprising the steps of: producing a seed culture by culturing a Rhodococcus koreensis strain; producing a pre-culture by pre-cultivating the seed culture; and inoculating the pre-culture into a culture medium containing oil and performing fermentation.
다른 양상은 로도코커스 코리엔시스(Rhodococcus koreensis) 배양액 또는 발효물을 포함하는, 피부 개선용 화장료 조성물을 제공한다.Another aspect provides a cosmetic composition for improving skin, comprising a culture or fermented product of Rhodococcus koreensis.
또 다른 양상은 로도코커스 코리엔시스(Rhodococcus koreensis) 균주 배양용 배지 조성물을 제공한다.Another aspect provides a medium composition for culturing a Rhodococcus koreensis strain.
또 다른 양상은 서열번호 1의 16S rRNA를 포함하는, 기탁번호 KCCM12825P로 기탁된 로도코커스 코리엔시스(Rhodococcus koreensis) BT1 균주 및 이의 배양액을 제공한다.Another aspect provides a Rhodococcus koreensis strain BT1 deposited under the accession number KCCM12825P, comprising 16S rRNA of
일 양상은 로도코커스 코리엔시스(Rhodococcus koreensis) 균주를 종균배양하여 종균배양물을 제조하는 단계; 상기 종균배양물을 전배양하여 전배양물을 제조하는 단계; 및 오일을 포함하는 배양 배지에 상기 전배양물을 접종하여 발효시키는 단계를 포함하는, 에멀젼 조성물의 제조방법을 제공하는 것이다. 구체적으로, 상기 에멀젼 조성물은 다중 에멀젼 조성물인 것을 특징으로 하는 것일 수 있다.One aspect is to provide a method for producing an emulsion composition, comprising the steps of: producing a seed culture by culturing a Rhodococcus koreensis strain; producing a pre-culture by pre-cultivating the seed culture; and inoculating the pre-culture into a culture medium containing oil and fermenting it. Specifically, the emulsion composition may be characterized in that it is a multiple emulsion composition.
본 명세서에서의 용어 "다중 에멀젼(multiple emulsion)"은 에멀젼 내에 더 작고 상이 다른 에멀젼으로 구성되어 있는 시스템으로, 에멀젼을 다른 연속상에 첨가하면서 교반할 때 생성되는 다상의 에멀젼을 의미할 수 있다. 다중 에멀젼은 크게 W/O/W (water in oil in water) 에멀젼과 O/W/O (oil in water in oil) 에멀젼으로 나뉠 수 있으며, 상기 W/O/W 다중 에멀젼은 내상의 W/O 에멀젼이 외부수상에 재분산된 형태로, 분산상 자체가 다른 작은 분산 입자를 포함하고 있어 연속상이 되는 중복 구조를 갖는 것일 수 있다.The term "multiple emulsion" in this specification refers to a system in which smaller emulsions of different phases are composed within an emulsion, and may mean a multi-phase emulsion generated when the emulsion is stirred while being added to another continuous phase. Multiple emulsions can be largely divided into W/O/W (water in oil in water) emulsions and O/W/O (oil in water in oil) emulsions. The W/O/W multiple emulsion is a form in which a W/O emulsion of an inner phase is redispersed in an outer water phase, and may have an overlapping structure in which the dispersed phase itself contains different small dispersed particles to become a continuous phase.
상기 다중 에멀젼 조성물은 W/O/W 다중 에멀젼 조성물일 수 있다. 구체적으로, 일 실시예에서는 Rhodococcus koreensis BT1(KCCM 13266P) 배양물을 포함하는 에멀젼의 수상부를 5-carboxyfluorescein 으로 염색하고 형광 현미경으로 관찰한 결과, 상대적으로 큰 에멀젼 내부에 수상으로 되어있는 작은 에멀젼들이 존재하는 다중상 구조인 것을 확인하였다(도 5).The above multiple emulsion composition may be a W/O/W multiple emulsion composition. Specifically, in one embodiment, the aqueous phase of an emulsion containing a Rhodococcus koreensis BT1 (KCCM 13266P) culture was stained with 5-carboxyfluorescein and observed under a fluorescence microscope, and it was confirmed that the multiphase structure had small emulsions in the aqueous phase within a relatively large emulsion (Fig. 5).
또한, 상기 다중 에멀젼 조성물은 바이오 액정의 형태를 갖는 것을 특징으로 하는 것일 수 있다. 본 명세서에서의 용어 "액정(Liquid crystal)"은 고체와 액체의 중간 상으로서 친수성과 친유성을 가지고 있는 유기분자들이 친수성 부분은 친수성끼리 소수성 부분은 소수성 부분끼리 일정하게 배열하여 여러 층을 이루고 있는 라멜라 구조를 형성하고 있을 때 생성되는 계를 의미하는 것으로, 본 명세서에서 용어 "바이오 액정"은 미생물의 발효 과정을 이용하여 제조된 액정을 의미할 수 있고, 이는 상기 로도코커스 코리엔시스 균주의 배양액 또는 발효물을 포함하는 것일 수 있다. In addition, the multi-emulsion composition may be characterized by having a form of a bio-liquid crystal. The term "liquid crystal" as used herein refers to a system that is created when organic molecules having hydrophilicity and lipophilicity as an intermediate phase between a solid and a liquid are arranged in a lamellar structure in which the hydrophilic parts are arranged hydrophilically and the hydrophobic parts are arranged hydrophobically to form multiple layers. The term "bio-liquid crystal" as used herein may refer to a liquid crystal manufactured using a fermentation process of a microorganism, and may include a culture solution or fermented product of the Rhodococcus coriensis strain.
상기 액정은 피부 각질층의 세포간 지질과 유사한 구조를 가지고 있어 피부 지질과의 친화성이 우수하고, 피부 보호막을 형성할 수 있어 화장료 조성물 등에 활용될 수 있다.The above liquid crystal has a structure similar to the intercellular lipid of the stratum corneum of the skin, so it has excellent affinity with skin lipids and can form a skin protective film, so it can be used in cosmetic compositions, etc.
또한, 상기 바이오 액정은 헥사고날형(hexagonal; Maltese cross) 다중막 입자상을 갖는 라멜라형 구상다중액정인 것을 특징으로 하며, 상기 바이오 액정 입자는 입경이 10 내지 50 ㎛일 수 있다. 일 실시예에서는, 발효 전/후 다중 에멀젼(실시예 1 및 비교예 1)을 현미경으로 촬영한 결과, 실시예 1의 경우 비교예 1인 발효 전과 비교하였을 때 발효 후 입자의 사이즈가 균일한 에멀젼이 형성됨을 확인하였다(도 1 및 도 2).In addition, the bio-liquid crystal is characterized by being a lamellar-type spherical multiple liquid crystal having a hexagonal (Maltese cross) multi-layer particle shape, and the bio-liquid crystal particle may have a particle size of 10 to 50 ㎛. In one embodiment, as a result of microscopically photographing multiple emulsions (Example 1 and Comparative Example 1) before and after fermentation, it was confirmed that in the case of Example 1, an emulsion with a uniform particle size was formed after fermentation compared to before fermentation in Comparative Example 1 (FIGS. 1 and 2).
본 발명에 있어서 발효 과정을 통해 바이오 액정 형태를 띨 수 있는 다중 에멀젼을 제조하는 미생물은 "로도코커스 코리엔시스(Rhodococcus koreensis)"일 수 있으며, 보다 구체적으로는 기탁번호 KCCM 13266P로 기탁된 Rhodococcus koreensis BT1 균주일 수 있다. 상기 Rhodococcus koreensis BT1 균주는 서열번호 1의 16s rRNA를 포함하는 것일 수 있다.In the present invention, the microorganism that produces a multiple emulsion capable of taking on a bio-liquid crystal form through a fermentation process may be " Rhodococcus koreensis", and more specifically, may be the Rhodococcus koreensis BT1 strain deposited under the deposit number KCCM 13266P. The Rhodococcus koreensis BT1 strain may include 16s rRNA of
상기 균주를 종균배양하여 종균배양물을 제조하는 단계, 상기 종균배양물을 전배양하여 전배양물을 제조하는 단계에 있어서 LB 배지를 사용하여 진탕 배양하는 것일 수 있으나, 상기 균주를 활성화하기 위해 필요한 성분을 포함하는 배지 또는 배양 방법이라면 이에 특별히 제한되는 것은 아니다. In the step of producing a culture by culturing the above strain as a spawn, and in the step of producing a culture by pre-culturing the above strain as a pre-culture, shaking culture may be performed using an LB medium, but there is no particular limitation to this as long as it is a medium or culture method that contains components necessary to activate the above strain.
일 실시예에 있어서, 상기 종균배양물 또는 전배양물을 제조하는 단계는 10 내지 30℃, 100 내지 300 rpm 조건에서 24 내지 72 시간 동안 수행되는 것일 수 있다. 또한, 오일을 포함하는 배양 배지에 상기 전배양물을 접종하여 발효물을 제조하는 단계는 10 내지 30℃, 100 내지 300 rpm, 0.5 내지 2.0 vvm, pH 5.5 내지 6.5의 호기 조건에서 24 내지 120 시간 동안 수행되는 것일 수 있다.In one embodiment, the step of preparing the seed culture or pre-culture may be performed under conditions of 10 to 30° C. and 100 to 300 rpm for 24 to 72 hours. In addition, the step of preparing a fermented product by inoculating the pre-culture into a culture medium containing oil may be performed under aerobic conditions of 10 to 30° C., 100 to 300 rpm, 0.5 to 2.0 vvm, and pH 5.5 to 6.5 for 24 to 120 hours.
상기 배양 배지는 활성화된 전배양물을 대상을 본 배양을 수행하기 위한 것으로, KH2PO4, K2HPO4, (NH4)2SO4, MgSO4·7H2O, H3BO4, CaCl2, NaMoO4·2H2O, FeNaEDTA, FeSO4·7H2O, ZnSO4·H2O, MnSO4·H2O, NiCl2·H2O, CuSO4·5H2O, MnCl2 및 CoCl2·6H2O로 이루어진 군에서 선택되는 어느 하나 이상을 포함하는 것일 수 있으며, 이에 특별히 제한되는 것은 아니다. 구체적으로, 상기 배양 배지는 KH2PO4, 0.5 내지 10 g/L, K2HPO4 5 내지 20 g/L, (NH4)2SO4 10 내지 30g/L, MgSO4·7H2O, 0.001 내지 2 g/L, H3BO4 1 내지 10 mg/L, CaCl2 1 내지 50 mg/L, NaMoO4·2H2O 1 내지 10 mg/L, FeNaEDTA 0.1 내지 1 mg/L, ZnSO4·H2O 0.1 내지 1 mg/L, MnSO4·H2O 0.01 내지 0.1 mg/L, NiCl2·H2O 0.01 내지 0.1 mg/L, CuSO4·5H2O 0.01 내지 0.1 mg/L, MnCl2 0.01 내지 0.1 mg/L, CoCl2·6H2O 0.01 내지 0.1 mg/L, 식물성 오일 1 내지 100 g/L을 포함할 수 있다. 또한, 상기 배양 배지는 추가로 물(정제수)을 포함할 수 있다.The above culture medium is for performing the main culture of the activated preculture, and may contain at least one selected from the group consisting of KH2PO4 , K2HPO4 , ( NH4 ) 2SO4 , MgSO4 · 7H2O , H3BO4 , CaCl2 , NaMoO4· 2H2O , FeNaEDTA , FeSO4 · 7H2O , ZnSO4 ·H2O , MnSO4· H2O , NiCl2 · H2O , CuSO4· 5H2O , MnCl2 , and CoCl2 · 6H2O , but is not particularly limited thereto. Specifically, the culture medium contains KH2PO4 , 0.5 to 10 g/L, K2HPO4 , 5 to 20 g/L, ( NH4 ) 2SO4 , 10 to 30 g/L, MgSO4 · 7H2O , 0.001 to 2 g/L, H3BO4 , 1 to 10 mg/L, CaCl2, 1 to 50 mg/L, NaMoO4 · 2H2O , 1 to 10 mg/L, FeNaEDTA, 0.1 to 1 mg/L, ZnSO4·H2O , 0.1 to 1 mg/L, MnSO4 · H2O , 0.01 to 0.1 mg/L, NiCl2 · H2O , 0.01 to 0.1 mg/L, CuSO4 · 5H2O , 0.01 to 0.1 mg/L, MnCl 2 0.01 to 0.1 mg/L, CoCl 2 ·6H 2 O 0.01 to 0.1 mg/L, and
상기 오일은 상기 미생물 또는 균주에 탄소원을 공급하기 위한 것으로, 식물성 오일일 수 있다. 상기 식물성 오일은 예를 들어, 카놀라, 포도씨, 해바라기씨, 올리브, 대두, 아르간, 쌀겨, 들깨, 참깨, 아몬드, 마카다미아, 로즈힙, 코코넛, 땅콩, 옥수수, 타이거 넛츠, 시어나무 열매, 기름야자, 배르가모트 열매, 비타민나무씨앗, 동백씨앗, 홍화씨앗, 살구씨앗, 양귀비씨앗, 달맞이꽃씨앗, 피마자씨앗, 녹차씨앗, 메도우폼씨앗, 아마씨, 햄프씨앗 및 유채씨로 이루어지는 군에서 선택되는 어느 하나 이상으로부터 추출된 것일 수 있고, 구체적으로는 유채씨 오일일 수 있으나, 이에 특별히 제한되는 것은 아니다.The above oil is for supplying a carbon source to the above microorganism or strain and may be a vegetable oil. The vegetable oil may be extracted from at least one selected from the group consisting of, for example, canola, grape seed, sunflower seed, olive, soybean, argan, rice bran, perilla seed, sesame seed, almond, macadamia, rosehip, coconut, peanut, corn, tiger nut, shea fruit, oil palm, bergamot fruit, vitamin tree seed, camellia seed, safflower seed, apricot seed, poppy seed, evening primrose seed, castor seed, green tea seed, meadowfoam seed, flax seed, hemp seed and rapeseed, and may be specifically, rapeseed oil, but is not particularly limited thereto.
일 실시예에 있어서, 상기 다중 에멀젼 조성물의 제조방법에서 상기 발효물을 제조하는 단계 이후 10 내지 100℃, 5 내지 200분 간 열처리하는 단계를 추가로 포함할 수 있다. 또한, 열처리하는 단계 이후 원심분리기를 이용하여 잔존하는 미생물 파쇄물을 제거하는 단계를 더 포함할 수 있다.In one embodiment, the method for producing the multi-emulsion composition may further include a step of heat treating at 10 to 100° C. for 5 to 200 minutes after the step of producing the fermented product. In addition, a step of removing remaining microbial fragments using a centrifuge may be further included after the step of heat treating.
다른 양상은 로도코커스 코리엔시스(Rhodococcus koreensis) 배양액 또는 발효물을 포함하는, 피부 개선용 화장료 조성물을 제공하는 것이다. 상기에서 설명한 내용과 동일한 부분은 상기 화장료 조성물에도 공히 적용된다.Another aspect is to provide a cosmetic composition for improving skin, comprising a culture or fermented product of Rhodococcus koreensis . The same parts as described above are also applied to the cosmetic composition.
상기 배양액 또는 발효물은 로도코커스 코리엔시스 균주를 종균배양하여 종균배양물을 제조하는 단계; 상기 종균배양물을 전배양하여 전배양물을 제조하는 단계; 및 오일을 포함하는 배양 배지에 상기 전배양물을 접종하여 발효물을 제조하는 단계를 통해 제조된 것일 수 있다. The above culture solution or fermented product may be produced through a step of producing a culture by culturing a Rhodococcus coriensis strain as a culture medium; a step of producing a pre-culture by pre-cultivating the culture medium; and a step of producing a fermented product by inoculating the pre-culture into a culture medium containing oil.
상기 피부 개선은 피부장벽 강화 또는 피부 보습일 수 있으나, 이에 특별히 제한되는 것은 아니다. 본 명세서에서 용어 "피부장벽 강화"는 피부 가장 바깥쪽에 위치하여 수분 등의 손실을 막아주는 피부 장벽의 기능이 증진되는 모든 작용을 의미할 수 있고, 상기 용어 "피부 보습"은 피부 내 수분을 유지하거나 수분 손실을 방지하는 모든 작용을 의미할 수 있다.The above skin improvement may be, but is not particularly limited to, skin barrier strengthening or skin moisturizing. In this specification, the term "skin barrier strengthening" may mean any action that enhances the function of the skin barrier, which is located at the outermost part of the skin and prevents moisture loss, and the term "skin moisturizing" may mean any action that maintains moisture in the skin or prevents moisture loss.
또한, 상기 화장료 조성물은 W/O/W 다중 에멀젼(multiple emulsion) 조성물인 것을 특징으로 하는 것일 수 있고, 상기 다중 에멀젼 조성물은 바이오 액정의 형태를 갖는 것을 특징으로 하는 것일 수 있다.In addition, the cosmetic composition may be characterized as being a W/O/W multiple emulsion composition, and the multiple emulsion composition may be characterized as having a form of bio-liquid crystal.
또 다른 양상은 로도코커스 코리엔시스(Rhodococcus koreensis) 균주 배양용 배지 조성물을 제공하는 것이다. 상기에서 설명한 내용과 동일한 부분은 상기 배지 조성물에도 공히 적용된다. 구체적으로, 상기 배지 조성물은 오일; 및 KH2PO4, K2HPO4, (NH4)2SO4, MgSO4·7H2O, H3BO4, CaCl2, NaMoO4·2H2O, FeNaEDTA, FeSO4·7H2O, ZnSO4·H2O, MnSO4·H2O, NiCl2·H2O, CuSO4·5H2O, MnCl2 및 CoCl2·6H2O로 이루어진 군에서 선택되는 어느 하나 이상을 포함할 수 있으며, 이에 특별히 제한되는 것은 아니다.Another aspect is to provide a medium composition for culturing a Rhodococcus koreensis strain. The same parts as described above are also applied to the medium composition. Specifically, the medium composition may include at least one selected from the group consisting of oil; and KH 2 PO 4 , K 2 HPO 4 , (NH 4 ) 2 SO 4 , MgSO 4 ·7H 2 O, H 3 BO 4 , CaCl 2 , NaMoO 4 ·2H 2 O, FeNaEDTA, FeSO 4 ·7H 2 O, ZnSO 4 ·H 2 O, MnSO 4 ·H 2 O, NiCl 2 ·H 2 O, CuSO 4 ·5H 2 O, MnCl 2 and CoCl 2 ·6H 2 O, but is not particularly limited thereto.
또 다른 양상은 서열번호 1의 16S rRNA를 포함하는, 기탁번호 KCCM12825P로 기탁된 로도코커스 코리엔시스(Rhodococcus koreensis) BT1 균주 및 이의 배양액을 제공하는 것이다.Another aspect provides a Rhodococcus koreensis BT1 strain deposited under the accession number KCCM12825P, comprising 16S rRNA of
본 발명은 미생물의 발효 중에 다중 에멀젼 조성물을 제조하는 방법 등에 관한 것으로 기존 다중 에멀젼의 복잡한 공정이 없이 사용성이 우수하고, 이러한 방법으로 제조된 다중 에멀젼 화장료 조성물은 바이오 액정 형태를 띨 수 있는 것으로 피부에 자극을 주지 않으면서 피부 장벽 강화 및 보습 효과가 우수하여 피부 개선 용도로 사용될 수 있다.The present invention relates to a method for producing a multiple emulsion composition during fermentation of microorganisms, which has excellent usability without the complicated process of existing multiple emulsions, and a multiple emulsion cosmetic composition produced by this method can take the form of a bio-liquid crystal, and has excellent effects of strengthening the skin barrier and moisturizing without irritating the skin, so that it can be used for skin improvement purposes.
도 1은 발효 전/후 본 발명의 다중 에멀젼(실시예 1 및 비교예 1)을 촬영한 현미경 사진을 나타낸 것이다.Figure 1 shows microscopic photographs of the multiple emulsions of the present invention (Example 1 and Comparative Example 1) before and after fermentation.
도 2는 발효 전/후의 다중 에멀젼(실시예 1 및 비교예 1) 입자 사이즈의 분포도를 나타낸 것이다.Figure 2 shows the particle size distribution of multiple emulsions (Example 1 and Comparative Example 1) before and after fermentation.
도 3은 실시예 1, 비교예 1 및 비교예 3 내지 6에서 균주별 유화 정도를 비교한 사진을 나타낸 것이다.Figure 3 shows photographs comparing the degree of emulsification by strain in Example 1, Comparative Example 1, and Comparative Examples 3 to 6.
도 4는 유화 현상을 띠는 발효물(실시예 1, 비교예 4 및 5)의 다중 에멀젼 형성 여부를 비교한 사진을 나타낸 것이다.Figure 4 shows a photograph comparing the formation of multiple emulsions in fermented products (Example 1, Comparative Examples 4 and 5) that exhibit emulsification.
도 5는 실시예 1에 대해 수상 염색에 따른 다중 에멀젼 형성 여부를 확인한 결과를 나타낸 것이다.Figure 5 shows the results of confirming whether multiple emulsions were formed according to water dyeing in Example 1.
도 6은 각각의 다중 에멀젼에서 바이오 액정의 형성 여부를 확인한 사진을 나타낸 것이다.Figure 6 shows a photograph confirming the formation of bio-liquid crystals in each multiple emulsion.
도 7은 바이오 액정 형태를 갖는 다중 에멀젼(실시예 1)의 열 안정성을 비교한 결과(열처리 전/후 촬영한 현미경 사진)를 나타낸 것이다.Figure 7 shows the results of comparing the thermal stability of a multiple emulsion (Example 1) having a bio-liquid crystal form (micrographs taken before and after heat treatment).
도 8은 본 발명의 다중 에멀젼 (실시예 1, 비교예 1 및 비교예 3 내지 6)이 피부 장벽 인자 필라그린(Filaggrin; FLG)의 발현에 미치는 영향을 비교한 결과를 나타낸 것이다.Figure 8 shows the results of comparing the effects of the multiple emulsions of the present invention (Example 1, Comparative Example 1, and Comparative Examples 3 to 6) on the expression of the skin barrier factor filaggrin (FLG).
도 9는 본 발명의 다중 에멀젼(실시예 1, 비교예 1)이 피부 장벽 인자 카스파제-14(Caspase-14; CASP-14)의 발현에 미치는 영향을 비교한 결과를 나타낸 것이다.Figure 9 shows the results of comparing the effects of the multiple emulsions of the present invention (Example 1, Comparative Example 1) on the expression of the skin barrier factor caspase-14 (CASP-14).
도 10은 본 발명의 다중 에멀젼(실시예 1, 비교예 1)이 수분 보습 인자 히알루로난 합성효소 2(Hyaluronic acid synthase-2; HAS-2)의 발현에 미치는 영향을 비교한 결과를 나타낸 것이다.Figure 10 shows the results of comparing the effects of the multiple emulsions of the present invention (Example 1, Comparative Example 1) on the expression of the moisture-retaining factor hyaluronan synthase-2 (Hyaluronic acid synthase-2; HAS-2).
이하 실시예를 통하여 보다 상세하게 설명한다. 그러나, 이들 실시예는 예시적으로 설명하기 위한 것으로 본 발명의 범위가 이들 실시예에 한정되는 것은 아니다.The present invention will be described in more detail through the following examples. However, these examples are provided for illustrative purposes only and the scope of the present invention is not limited to these examples.
실시예 1. 로도코커스 코리엔시스 균주 배양물을 포함하는 에멀젼 제조Example 1. Preparation of an emulsion containing a culture of Rhodococcus coriensis strain
Rhodococcus koreensis BT1(KCCM 13266P, 2022.11.11)을 LB 배지에 접종하여 30℃, 200 rpm에서 48시간 동안 진탕 배양하여 종균 배양을 진행하였다. 전배양은 상기 종균 배양액을 멸균된 LB 배지에 1% 접종하여 30℃, 200 rpm에서 24시간 동안 진탕 배양하여 전배양을 진행하였다. 전배양까지 균의 활성화를 최대한 유도하여 본 배양에서의 다중 에멀젼 형성을 유도하고자 하였다. Rhodococcus koreensis BT1 (KCCM 13266P, 2022.11.11) was inoculated into LB medium and shaken at 30°C and 200 rpm for 48 hours to culture the spawn. Preculture was performed by inoculating 1% of the spawn culture into sterilized LB medium and shaking at 30°C and 200 rpm for 24 hours to culture the spawn. The goal was to induce maximum bacterial activation up to preculture to induce multiple emulsion formation in the main culture.
본 배양을 위해 KH2PO4 5 g/L, K2HPO4 10 g/L, (NH4)2SO4 20 g/L, MgSO4·7H2O 0.2 g/L, H3BO4 5 mg/L, CaCl2 20 mg/L, NaMoO4·2H2O 5 mg/L, FeNaEDTA 0.5 mg/L, ZnSO4·H2O 0.5 mg/L, MnSO4·H2O 0.04 mg/L, NiCl2·H2O 0.02 mg/L, CuSO4·5H2O 0.04 mg/L, MnCl2 0.02 mg/L, CoCl2·6H2O 0.04 mg/L, 유채씨 오일 25 g/L로 구성된 배지 3.5 L를 5L 발효조에 준비하였다. 해당 배지에 전배양발효물을 1 % 접종하여 30℃, 100 rpm, pH 6.0 보정, 0.5 vvm 조건에서 96시간 배양하였다. For the main culture, the medium was composed of KH2PO4 5 g/L, K2HPO4 10 g/L, ( NH4 ) 2SO4 20 g/L, MgSO4 ·7H2O 0.2 g/L, H3BO4 5 mg/L, CaCl2 20 mg/L, NaMoO4 · 2H2O 5 mg/L, FeNaEDTA 0.5 mg/L, ZnSO4 · H2O 0.5 mg/L, MnSO4 · H2O 0.04 mg/L, NiCl2 · H2O 0.02 mg/L, CuSO4·5H2O 0.04 mg/L, MnCl2 0.02 mg/L, CoCl2 · 6H2O 0.04 mg/L, and rapeseed oil 25 g/ L . 3.5 L was prepared in a 5 L fermenter. The medium was inoculated with 1% of the pre-culture fermentation product and cultured for 96 hours under the conditions of 30°C, 100 rpm, pH 6.0 correction, and 0.5 vvm.
비교예 1. 본 배양 0 시간의 에멀젼Comparative Example 1. Emulsion at 0 hour of culture
상기 실시예 1의 본 배양까지 제조방식은 모두 동일하며, 배양 0 시간일 때를 비교예 1로 하였다.The manufacturing method up to the main culture of the above Example 1 was the same, and the time at which the culture was 0 hours was set as Comparative Example 1.
비교예 2. 일반 액정 에멀젼의 제조Comparative Example 2. Preparation of general liquid crystal emulsion
일반적으로 화장품 분야에서 널리 사용되는 액정 제조 방법으로, 호모믹서를 이용하여 액정 에멀젼을 제조하였다. 하기 표 1은 액정 에멀젼을 만들기 위한 대표적인 조성비를 나타내었다. 구체적으로, 수상을 총량이 100g이 되도록 정확하게 계량한 다음, 75~80℃ 까지 가온하여 완전히 용해시키고 별도로 보관하였다. 또한, 유상을 정확하게 계량하여 75~80℃ 까지 가온하여 완전히 용해시킨 다음 별도로 보관하였다. 이후 호모믹서를 사용하여 수상에다 유상을 서서히 투입하면서 충분하게 분산시키고, 5분간 3,000 rpm 정도로 유화 반응을 시켰다. 이후 상온에서 냉각하여 탈포 공정 후 완료하였다.This is a liquid crystal manufacturing method widely used in the cosmetics field, and a liquid crystal emulsion was manufactured using a homomixer. Table 1 below shows representative composition ratios for making a liquid crystal emulsion. Specifically, the water phase was accurately weighed so that the total amount was 100 g, heated to 75 to 80°C to completely dissolve, and stored separately. In addition, the oil phase was accurately weighed, heated to 75 to 80°C to completely dissolve, and stored separately. Afterwards, the oil phase was slowly added to the water phase using a homomixer to sufficiently disperse it, and an emulsification reaction was performed at about 3,000 rpm for 5 minutes. Afterwards, it was cooled to room temperature to complete the defoaming process.
(Water phase)(Water phase)
(Oil phase)(Oil phase)
비교예 3 내지 6. 균주별 에멀젼 형성 조건 Comparative examples 3 to 6. Emulsion formation conditions by strain
균주별 에멀젼 형성 비교실험은 Rhodococcus erythropolis KCCM40161 (비교예 3), Rhodococcus ruber KCCM41053 (비교예 4), Rhodococcus opacus KCCM41722 (비교예 5), Candia bombiocola KCCM11858 (비교예 6)으로 총 4가지 균주로 진행하였다. A comparative experiment on emulsion formation by strain was conducted with a total of four strains: Rhodococcus erythropolis KCCM40161 (Comparative Example 3), Rhodococcus ruber KCCM41053 (Comparative Example 4), Rhodococcus opacus KCCM41722 (Comparative Example 5), and Candia bombiocola KCCM11858 (Comparative Example 6).
Rhodococcus erythropolis KCCM40161를 LB 배지에 접종하여 26℃, 200 rpm에서 24시간 동안 진탕 배양하여 종균 배양을 진행하였다. 전배양은 상기 종균 배양액을 멸균된 LB 배지에 1% 접종하여 26℃, 200 rpm에서 24시간 동안 진탕 배양하여 전배양을 진행하였다. 전배양까지 균의 활성화를 최대한 유도하여 본 배양에서의 유화 현상을 유도하고자 하였다. Rhodococcus erythropolis KCCM40161 was inoculated into LB medium and cultured with shaking at 26°C and 200 rpm for 24 hours to culture the spawn. Preculture was performed by inoculating 1% of the above spawn culture into sterilized LB medium and cultured with shaking at 26°C and 200 rpm for 24 hours to culture the spawn. The aim was to induce the emulsification phenomenon in the main culture by maximally inducing the activation of the bacteria up to the preculture.
본 배양을 위해 KH2PO4 5 g/L, K2HPO4 10 g/L, (NH4)2SO4 20 g/L, MgSO4·7H2O 0.2 g/L, H3BO4 5 mg/L, CaCl2 20 mg/L, NaMoO4·2H2O 5 mg/L, FeNaEDTA 0.5 mg/L, ZnSO4·H2O 0.5 mg/L, MnSO4·H2O 0.04 mg/L, NiCl2·H2O 0.02 mg/L, CuSO4·5H2O 0.04 mg/L, MnCl2 0.02 mg/L, CoCl2·6H2O 0.04 mg/L, 유채씨 오일 25 g/L로 구성된 배지 3.5 L를 5L 발효조에 준비하였다. 해당 배지에 전배양발효물을 1 % 접종하여 26℃, 100 rpm, pH 6.0 보정, 0.5 vvm 조건에서 96시간 배양하였다. For the main culture, the medium was composed of KH2PO4 5 g/L, K2HPO4 10 g/L, ( NH4 ) 2SO4 20 g/L, MgSO4 ·7H2O 0.2 g/L, H3BO4 5 mg/L, CaCl2 20 mg/L, NaMoO4 · 2H2O 5 mg/L, FeNaEDTA 0.5 mg/L, ZnSO4 · H2O 0.5 mg/L, MnSO4 · H2O 0.04 mg/L, NiCl2 · H2O 0.02 mg/L, CuSO4·5H2O 0.04 mg/L, MnCl2 0.02 mg/L, CoCl2 · 6H2O 0.04 mg/L, and rapeseed oil 25 g/ L . 3.5 L was prepared in a 5 L fermenter. The medium was inoculated with 1% of the pre-culture fermentation product and cultured for 96 hours under the conditions of 26°C, 100 rpm, pH 6.0 correction, and 0.5 vvm.
Rhodococcus ruber KCCM41053를 LB 배지에 접종하여 28℃, 200 rpm에서 48시간 동안 진탕 배양하여 종균 배양을 진행하였다. 전배양은 상기 종균 배양액을 멸균된 LB 배지에 1% 접종하여 28℃, 250 rpm에서 24시간 동안 진탕 배양하여 전배양을 진행하였다. 전배양까지 균의 활성화를 최대한 유도하여 본배양에서의 유화 현상을 유도하고자 하였으며, 본 배양 조건은 실시예1의 조건과 동일하게 하였다. Rhodococcus ruber KCCM41053 was inoculated into LB medium and cultured with shaking at 28°C and 200 rpm for 48 hours to culture the spawn. Preculture was performed by inoculating 1% of the above spawn culture into sterilized LB medium and cultured with shaking at 28°C and 250 rpm for 24 hours to culture the spawn. The aim was to induce maximum activation of the bacteria up to the preculture to induce the emulsification phenomenon in the main culture, and the conditions for the main culture were the same as those of Example 1.
Rhodococcus opacus KCCM41722를 LB 배지에 접종하여 30℃, 200 rpm에서 48시간 동안 진탕 배양하여 종균 배양을 진행하였다. 전배양은 상기 종균 배양액을 멸균된 LB 배지에 1% 접종하여 30℃, 200rpm에서 24시간 동안 진탕 배양하여 전배양을 진행하였다. 전배양까지 균의 활성화를 최대한 유도하여 본배양에서의 유화 현상을 유도하고자 하였으며, 본 배양 조건은 실시예1의 조건과 동일하게 하였다. Rhodococcus opacus KCCM41722 was inoculated into LB medium and cultured with shaking at 30°C and 200 rpm for 48 hours to culture the spawn. Preculture was performed by inoculating 1% of the above spawn culture into sterilized LB medium and cultured with shaking at 30°C and 200 rpm for 24 hours to culture the spawn. The preculture was performed to induce the emulsification phenomenon in the main culture by inducing the maximum activation of the bacteria up to the preculture, and the main culture conditions were the same as those of Example 1.
Candia bombiocola KCCM11858를 YM 배지에 접종하여 30℃, 200 rpm에서 48시간 동안 진탕 배양하여 종균 배양을 진행하였다. 전배양은 상기 종균 배양액을 멸균된 YM 배지에 1% 접종하여 30℃, 200rpm에서 24시간 동안 진탕 배양하여 전배양을 진행하였다. 전배양까지 균의 활성화를 최대한 유도하여 본배양에서의 유화 현상을 유도하고자 하였으며, 본 배양 조건은 실시예1의 조건과 동일하게 하였다. Candia bombiocola KCCM11858 was inoculated into YM medium and cultured with shaking at 30°C and 200 rpm for 48 hours to culture the spawn. Preculture was performed by inoculating 1% of the above spawn culture into sterilized YM medium and cultured with shaking at 30°C and 200 rpm for 24 hours to culture the spawn. The preculture was performed to induce the emulsification phenomenon in the main culture by inducing the maximum activation of the fungus up to the preculture, and the main culture conditions were the same as those of Example 1.
실험예 1. W/O/W 의 다중 에멀젼 형성 여부 관찰 Experimental Example 1. Observation of the formation of multiple emulsions of W/O/W
발효 전/후 다중 에멀젼(실시예 1 및 비교예 1)을 현미경으로 촬영한 결과, 실시예 1의 경우 비교예 1인 발효 전과 비교하였을 때 발효 후 입자의 사이즈가 균일한 에멀젼이 형성됨을 확인하였다(도 1 및 도 2).As a result of taking microscopic photographs of multiple emulsions (Example 1 and Comparative Example 1) before and after fermentation, it was confirmed that in the case of Example 1, an emulsion with uniform particle size was formed after fermentation compared to before fermentation in Comparative Example 1 (Figs. 1 and 2).
또한, 실시예 1에 대하여 수상부를 5-carboxyfluorescein 으로 염색하고 형광 현미경으로 관찰한 결과, 상대적으로 큰 에멀젼 내부에 수상으로 되어있는 작은 에멀젼들이 존재하는 것을 확인하였고(도 5), 이로부터 실시예 1의 배양물을 포함하는 에멀젼의 구조가 W/O/W의 다중 에멀젼(multiple emulsion)임을 확인하였다.In addition, for Example 1, the aqueous phase was stained with 5-carboxyfluorescein and observed under a fluorescence microscope, and it was confirmed that small emulsions in the aqueous phase existed inside a relatively large emulsion (Fig. 5), and from this, it was confirmed that the structure of the emulsion including the culture of Example 1 was a multiple emulsion of W/O/W.
실험예 2. 균주별 유화력 및 다중 에멀젼 형성 여부 비교 Experimental Example 2. Comparison of emulsifying power and multiple emulsion formation by strain
실시예 1 과 비교예 3 내지 6에 대해 균주 별 유화력을 비교 평가하였다. 그 결과, 본 발명의 Rhodococcus koreensis BT1의 균주를 사용한 실시예 1에서 가장 높은 유화력을 보였다. 비교예 3 및 6은 유화되지 않음을 확인하였으며, 비교예 4 및 5는 비교예 3 및 6에 비해 유화 양상이 관찰되나 실시예 1에 비해 유화 정도 및 안정도에 큰 차이를 보이는 것을 확인하였다(도 3).The emulsifying power of each strain was compared and evaluated for Example 1 and Comparative Examples 3 to 6. As a result, Example 1 using the strain of Rhodococcus koreensis BT1 of the present invention showed the highest emulsifying power. It was confirmed that Comparative Examples 3 and 6 were not emulsified, and Comparative Examples 4 and 5 showed an emulsifying appearance compared to Comparative Examples 3 and 6, but showed a large difference in the degree of emulsification and stability compared to Example 1 (Fig. 3).
또한, 유화 현상을 띠는 발효물(실시예 1, 비교예 4 및 5)에 대해 다중 에멀젼 형성 여부를 비교한 결과, 실시예 1은 큰 에멀젼 내부에 작은 에멀젼들이 관찰되어 다중 에멀젼이 형성됨을 관찰할 수 있었으나, 비교예 4 및 5는 이러한 다중 에멀젼의 구조가 관찰되지 않음을 확인하였다(도 4).In addition, as a result of comparing whether multiple emulsions were formed for the fermented products exhibiting emulsification (Example 1, Comparative Examples 4 and 5), it was observed that Example 1 formed a multiple emulsion by observing small emulsions inside a large emulsion, but it was confirmed that such a multiple emulsion structure was not observed for Comparative Examples 4 and 5 (Fig. 4).
실험예 4. 다중 에멀젼의 바이오 액정 형성 여부 관찰Experimental Example 4. Observation of the formation of bio-liquid crystals in multiple emulsions
상기 실시예 1과 비교예 1 및 2에 대하여 편광 현미경 Polarizing Microscope(BX53T-32F01, Olympus, Japan)을 이용하여 라멜라 구조의 액정 형성 여부를 판단한 결과를 도 6에 나타내었다. The results of determining whether a liquid crystal with a lamellar structure was formed using a polarizing microscope (BX53T-32F01, Olympus, Japan) for Example 1 and Comparative Examples 1 and 2 are shown in Fig. 6.
그 결과, 실시예 1의 경우 액정을 형성하는 것으로 알려진 비교예 2와 유사하게 몰타 크로스(Maltese cross) 형태가 관찰되는 것을 확인할 수 있었다. 반면, 계면 활성제를 사용하지 않고 액정 형성과 무관한 물질들로 구성된 비교예 1 의 경우에는 몰타 크로스 형태가 전혀 관찰되지 않았다(도 6). As a result, in the case of Example 1, it was confirmed that a Maltese cross shape was observed similarly to Comparative Example 2, which is known to form a liquid crystal. On the other hand, in the case of Comparative Example 1, which was composed of materials unrelated to liquid crystal formation and did not use a surfactant, the Maltese cross shape was not observed at all (Fig. 6).
실험예 5. 열처리에 따른 바이오 액정 형태를 갖는 다중 에멀젼의 열 안정성 평가Experimental Example 5. Evaluation of thermal stability of multiple emulsions with bio-liquid crystal form according to heat treatment
상기 실시예 1에 대해 열처리에 따른 다중 에멀젼의 안정도를 평가하였다. 구체적으로, 실시예 1의 에멀젼을 70℃, 30분 간 열처리한 후 편광현미경으로 상태를 관찰하였다. 입자 크기 분석은 SLS(LA-960, Horiba, Japan)을 사용하였다. 그 결과, 실시예 1의 경우 열처리 전/후를 비교하여서도 에멀젼의 상태와 입자의 크기에 대해 열 안정성을 나타냄을 확인하였다(도 7).For the above Example 1, the stability of the multiple emulsion according to the heat treatment was evaluated. Specifically, the emulsion of Example 1 was heat treated at 70℃ for 30 minutes and then the state was observed using a polarizing microscope. The particle size analysis was performed using SLS (LA-960, Horiba, Japan). As a result, in the case of Example 1, it was confirmed that the emulsion state and particle size exhibited thermal stability by comparing before and after the heat treatment (Fig. 7).
실험예 6. 관능평가Experimental Example 6. Sensory Evaluation
상기 실시예 1 및 비교예 2 내지 5의 사용성에 대한 관능평가를 실시하였다. 평가 요원 10명으로 하여금 상기 실시예 1, 비교예 2 내지 5의 조성물을 도포하게 한 후, 발림성, 보습력, 끈적임, 발효취 항목에 대하여 비교 테스트를 하도록 하였으며, 이를 10점 척도로 평가하였다. 그 결과는 하기 표 2에 나타내었다. ([평가점수] 1점/---: 가장 나쁨, 불쾌취 있음, 10점/+++: 가장 좋음, 불쾌취 없음). 하기 표 2에 따르면, 본 발명에 따른 다중 에멀젼인 실시예 1의 경우 비교예 3 내지 5에 비하여 발림성이 우수하며, 발효 시 발생되는 특유의 발효취 또한 현저히 발생되지 않음을 알 수 있다. 또한, 실시예 1의 경우 비교예 2 내지 5에 비하여 끈적임이 적으며 가장 높은 보습력을 가지는 것을 확인하였다. 이를 통하여 본 발명의 다중 에멀젼 조성물은 발효 조성물 특유의 발효취가 거의 없으며 친환경적이고 우수한 사용감을 가짐을 확인하였다.A sensory evaluation was conducted on the usability of the above Example 1 and Comparative Examples 2 to 5. Ten evaluators applied the compositions of Example 1 and Comparative Examples 2 to 5, and then conducted a comparative test on the items of spreadability, moisturizing power, stickiness, and fermentation odor, and evaluated them on a 10-point scale. The results are shown in Table 2 below. ([Evaluation score] 1 point/---: worst, with unpleasant odor, 10 points/+++: best, without unpleasant odor). According to Table 2 below, Example 1, which is a multiple emulsion according to the present invention, has excellent spreadability compared to Comparative Examples 3 to 5, and also does not significantly generate the unique fermentation odor generated during fermentation. In addition, it was confirmed that Example 1 had less stickiness and the highest moisturizing power compared to Comparative Examples 2 to 5. Through this, it was confirmed that the multi-emulsion composition of the present invention has almost no fermentation odor characteristic of fermented compositions, is environmentally friendly, and has excellent usability.
실험예 7. 다중 에멀젼의 피부 장벽 강화 및 보습 효과 확인 Experimental Example 7. Confirmation of the skin barrier strengthening and moisturizing effects of multiple emulsions
실시예 1의 다중 에멀젼이 피부 장벽과 보습 관련된 인자에 미치는 영향을 분석하였다. 구체적으로, 인간 표피세포 (HaCaT)와 인간 진피섬유아세포 (Human dermal fibroblast)를 각각 10% 우태아혈청(FBS)과 1% 페니실린을 포함하는 DMEM (Dulbecco's Modified Eagle's Medium) 배지와 37℃, 5% CO2 배양기를 사용하여 배양하였다. 96 well plate에 3.0 x 104 개의 세포를 분주한 뒤 24시간 동안 배양기에서 배양하였다. 24시간 뒤 새로운 배지로 교체하고 실시예 1의 다중 에멀젼 시료를 원하는 농도로 처리하여 24시간 배양하였다. 배양 후 식염수로 충분히 세척하여 cDNA를 합성하고 100 ng/mL씩 정량한 다음, Real-time Quantitative Polymerase Chain Reaction (RT-qPCR)을 진행하였다. 표피세포를 사용하여 피부 장벽 인자인 Filaggrin(FLG) 및 Caspase-14(CASP-14)의 발현을 확인하였으며, 진피섬유아세포를 사용하여 보습 인자인 Hyaluronic acid synthase-2(HAS-2)의 발현을 확인하였다. 상대적인 발현율은 각 유전자의 발현 양은 Housekeeping gene인 β-actin의 발현 양으로 Normalization하여 상대적인 발현율을 나타내었다. 실시예 1과 비교예 1, 비교예 3 내지 6의 피부 장벽 인자인 FLG 발현에 미치는 영향을 도 8에 나타내었고, CASP-14 발현에 미치는 영향을 확인하여 도 9에, HAS-2 발현에 미치는 영향은 도 10에 나타내었다.The effects of the multiple emulsion of Example 1 on the skin barrier and moisturizing-related factors were analyzed. Specifically, human epidermal cells (HaCaT) and human dermal fibroblasts were cultured using DMEM (Dulbecco's Modified Eagle's Medium) medium containing 10% fetal bovine serum (FBS) and 1% penicillin, respectively, at 37°C in a 5% CO2 incubator. 3.0 x 10 4 cells were dispensed into a 96-well plate and cultured in an incubator for 24 hours. After 24 hours, the medium was replaced with new one, and the multiple emulsion sample of Example 1 was treated at the desired concentration and cultured for 24 hours. After culture, the cells were sufficiently washed with saline solution, cDNA was synthesized, and quantified at 100 ng/mL, and then Real-time Quantitative Polymerase Chain Reaction (RT-qPCR) was performed. The expression of Filaggrin (FLG) and Caspase-14 (CASP-14), which are skin barrier factors, was confirmed using epidermal cells, and the expression of Hyaluronic acid synthase-2 (HAS-2), which is a moisturizing factor, was confirmed using dermal fibroblasts. The relative expression rate was expressed by normalizing the expression amount of each gene to the expression amount of β-actin, which is a housekeeping gene. The effects of Example 1 and Comparative Example 1 and Comparative Examples 3 to 6 on the expression of FLG, a skin barrier factor, are shown in Fig. 8, the effects on CASP-14 expression are shown in Fig. 9, and the effects on HAS-2 expression are shown in Fig. 10.
그 결과, 피부 장벽 인자인 Filaggrin의 발현은 실시예 1에 의해 가장 크게 증가하였고, 이에 피부 장벽 효과가 가장 높게 나타남을 확인하였다. 그 외 비교예에서는 무처리군(Control) 대비 뚜렷한 FLG 발현 증가 효과를 보이지 않았다(도 8). 또한, 실시예 1은 무처리군 및 비교예 1 대비 또 다른 피부장벽인자인 CASP-14와 수분보습인자인 HAS-2의 발현을 증가시키는 것을 확인하였다(도 9 및 도 10).As a result, the expression of Filaggrin, a skin barrier factor, was most significantly increased by Example 1, and it was confirmed that the skin barrier effect was the highest. In other comparative examples, no significant increase in FLG expression was observed compared to the untreated group (Control) (Fig. 8). In addition, it was confirmed that Example 1 increased the expression of CASP-14, another skin barrier factor, and HAS-2, a moisture retention factor, compared to the untreated group and Comparative Example 1 (Figs. 9 and 10).
전술한 본 발명의 설명은 예시를 위한 것이며, 본 발명이 속하는 기술분야의 통상의 지식을 가진 자는 본 발명의 기술적 사상이나 필수적인 특징을 변경하지 않고서 다른 구체적인 형태로 쉽게 변형이 가능하다는 것을 이해할 수 있을 것이다. 그러므로 이상에서 기술한 실시예들은 모든 면에서 예시적인 것이며 한정적이 아닌 것으로 이해해야만 한다.The above description of the present invention is for illustrative purposes only, and those skilled in the art will understand that the present invention can be easily modified into other specific forms without changing the technical idea or essential characteristics of the present invention. Therefore, it should be understood that the embodiments described above are exemplary in all respects and not restrictive.
[수탁번호][Acceptance number]
기탁기관명 : 한국미생물보존센터(KCCM)Name of depositor: Korea Center for Microbiological Conservation (KCCM)
수탁번호 : KCCM13266PAccession number: KCCM13266P
수탁일자 : 20221111Date of Consignment: 20221111
Claims (19)
Applications Claiming Priority (4)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| KR20230015726 | 2023-02-06 | ||
| KR10-2023-0015726 | 2023-02-06 | ||
| KR10-2023-0105824 | 2023-08-11 | ||
| KR1020230105824A KR102780609B1 (en) | 2023-02-06 | 2023-08-11 | Composition for improving skin condition comprising an emulsion using Rhodococcus koreensis and fermented product thereof |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| WO2024167084A1 true WO2024167084A1 (en) | 2024-08-15 |
Family
ID=92263129
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| PCT/KR2023/014289 Ceased WO2024167084A1 (en) | 2023-02-06 | 2023-09-20 | Emulsion using rhodococcus koreensis strain and composition for improving skin condition comprising fermented product thereof |
Country Status (1)
| Country | Link |
|---|---|
| WO (1) | WO2024167084A1 (en) |
Citations (5)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| KR100328913B1 (en) * | 1999-07-14 | 2002-03-20 | 복성해 | New species Rhodococcus koreensis DNP505 decomposing 2,4-dinitrophenol |
| KR101648130B1 (en) * | 2012-07-23 | 2016-08-16 | 주식회사 엘씨에스바이오텍 | Method for producing microorganism lamella construct and composition comprising microorganism lamella construct |
| KR20170012743A (en) * | 2015-07-23 | 2017-02-03 | 코스맥스 주식회사 | preparing method of make-up cleansing composition using liquid crystal phase |
| KR102335647B1 (en) * | 2020-05-26 | 2021-12-08 | 주식회사 유나이티드엑티브 | Fermented-nanoemulsion and preparation method thereof |
| KR102416730B1 (en) * | 2021-11-09 | 2022-07-05 | 주식회사 유나이티드엑티브 | Preparation method of fermented vegetable oil using skin flora and cosmetic composition comprising thereof |
-
2023
- 2023-09-20 WO PCT/KR2023/014289 patent/WO2024167084A1/en not_active Ceased
Patent Citations (5)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| KR100328913B1 (en) * | 1999-07-14 | 2002-03-20 | 복성해 | New species Rhodococcus koreensis DNP505 decomposing 2,4-dinitrophenol |
| KR101648130B1 (en) * | 2012-07-23 | 2016-08-16 | 주식회사 엘씨에스바이오텍 | Method for producing microorganism lamella construct and composition comprising microorganism lamella construct |
| KR20170012743A (en) * | 2015-07-23 | 2017-02-03 | 코스맥스 주식회사 | preparing method of make-up cleansing composition using liquid crystal phase |
| KR102335647B1 (en) * | 2020-05-26 | 2021-12-08 | 주식회사 유나이티드엑티브 | Fermented-nanoemulsion and preparation method thereof |
| KR102416730B1 (en) * | 2021-11-09 | 2022-07-05 | 주식회사 유나이티드엑티브 | Preparation method of fermented vegetable oil using skin flora and cosmetic composition comprising thereof |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| EP1132463B1 (en) | Cosmetic composition comprising an antagonist of the neuropeptide Y receptor | |
| DE3789435T2 (en) | Process for the preparation of eicosapentaenoic acid. | |
| EP4037651A1 (en) | Novel skin care composition | |
| WO2019235840A2 (en) | Fermented emulsifier for forming reverse micelle, composition comprising same and method for producing fermented emulsifier | |
| WO2023085578A1 (en) | Method for preparing fermented vegetable oil by means of skin flora, and cosmetic composition comprising same | |
| CN114901245B (en) | New skin care composition | |
| EP4037769A1 (en) | Novel skin care composition | |
| WO2021063528A1 (en) | Novel skin care composition | |
| WO2024167084A1 (en) | Emulsion using rhodococcus koreensis strain and composition for improving skin condition comprising fermented product thereof | |
| WO2021241953A1 (en) | Fermented nano-emulsifier composition and preparation method therefor | |
| DE69900547T2 (en) | COSMETIC COMPOSITION CONTAINING A MIXTURE FOR STIMULATING INTERLEUKIN-6 PRODUCTION | |
| CN112402335A (en) | Water-bursting powder and preparation method thereof | |
| CN111568814A (en) | Biological fermentation skin care emulsion and preparation method thereof | |
| WO2020085857A9 (en) | Transdermal delivery system comprising reverse micelle | |
| EP4037655A1 (en) | Novel skin care composition | |
| KR102780609B1 (en) | Composition for improving skin condition comprising an emulsion using Rhodococcus koreensis and fermented product thereof | |
| KR102761538B1 (en) | A cosmetic composition containing culture medium of Fucidium coccineum and Streptococcus genus and uses thereof | |
| CN113164531A (en) | External preparation for promoting hair growth or preventing alopecia | |
| EP4037644A1 (en) | Novel skin care composition | |
| CN111166701A (en) | Composition for external application to skin | |
| CN117836400A (en) | Novel Sphingomonas paucimobilis strain and application thereof | |
| KR102789598B1 (en) | Cosmetic composition and manufacturing method for improving skin condition containing spicules, lactic acid bacteria exosomes, and ceramides | |
| CN113750000A (en) | A kind of seal repair skin care product formula and preparation method thereof | |
| Xiong et al. | Accelerating the healing of rotator cuff tear through comprehensive repair strategy based on bioactive Cu2O-Decorated MXene Nanosheet | |
| KR102738315B1 (en) | A reverse liposome comprising culture medium of Fucidium coccineum and uses thereof |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| 121 | Ep: the epo has been informed by wipo that ep was designated in this application |
Ref document number: 23921458 Country of ref document: EP Kind code of ref document: A1 |
|
| NENP | Non-entry into the national phase |
Ref country code: DE |